Home > Boards > US Listed > Biotechs > AEterna Zentaris Inc. (AEZS)

Very true. this sort of funding is basically

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Hedge Starz Member Profile
 
Followed By 216
Posts 32,187
Boards Moderated 0
Alias Born 02/12/08
160x600 placeholder
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/10/2019 4:01:58 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/6/2019 2:32:15 PM
Aeterna Zentaris Provides Corporate Update GlobeNewswire Inc. - 6/6/2019 2:06:40 PM
Amended Securities Registration (section 12(b)) (8-a12b/a) Edgar (US Regulatory) - 5/9/2019 4:32:19 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/9/2019 4:10:06 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/9/2019 6:08:45 AM
Aeterna Zentaris Announces Results of Annual and Special Shareholders’ Meeting GlobeNewswire Inc. - 5/8/2019 6:04:22 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/7/2019 5:23:29 PM
Aeterna Zentaris Reports First Quarter 2019 Financial and Operating Results GlobeNewswire Inc. - 5/7/2019 5:12:12 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/7/2019 4:40:07 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/1/2019 6:24:31 AM
Annual and Transition Report (foreign Private Issuer) (20-f) Edgar (US Regulatory) - 4/1/2019 6:03:58 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/27/2019 2:04:26 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/26/2019 5:28:03 PM
Aeterna Zentaris Reports Fourth Quarter and Full-Year 2018 Financial and Operating Results GlobeNewswire Inc. - 3/26/2019 5:22:03 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/22/2019 4:43:08 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/19/2019 8:02:18 AM
Aeterna Zentaris to Announce Fourth Quarter and Year End 2018 Financial and Operating Results on March 26, 2019 GlobeNewswire Inc. - 3/19/2019 8:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 3/18/2019 6:09:40 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/12/2019 4:51:23 PM
Aeterna Zentaris Announces Strategic Review and Engagement of Financial Advisor GlobeNewswire Inc. - 3/12/2019 4:32:37 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/22/2019 1:18:07 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/11/2019 3:28:01 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/11/2019 1:42:02 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 1/16/2019 9:09:31 AM
Hedge Starz   Thursday, 09/10/15 09:38:00 AM
Re: Rymankoly post# 6269
Post # of 16211 
Very true. this sort of funding is basically a big F U to shareholders from mgmt. It should be illegal in the sense that it is Always destructive to shareholder value....considering they can Short a Stock into oblivion while converting shares at basement prices. Who is to stop a well organized team from converting shares at .009 - below a penny? They can control companies this way all in the name of some biotech not wanting to lose their jobs. In the end....they can reissue themselves shares if the pipeline and plan succeed.

THey will herald the company as a SUCCESS, when in reality they established no value considering the dilution that took place to get them there. It is an Illusion of success with these biotech companies who claim they Hit it Big. No, they did not. Whoever was allowed to get cheap stock in the end will win big.

IT is a major problem, and the Exchanges should be ashamed of themselves along with any company that does this. It is basically a professional Short and Load and Grab Market Share then Pump program.


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist